BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pathak S, Nunes QM, Daniels IR, Smart NJ. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review. Colorectal Dis 2014;16:769-76. [PMID: 25039573 DOI: 10.1111/codi.12700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Üçüncü MZ. Kolorektal Kanserlerin Tanı ve Prognostik Takibinde Eski ve Yeni Serum Biyobelirteçleri: Sistematik İnceleme ve Meta-Analiz. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi 2019. [DOI: 10.38079/igusabder.592956] [Reference Citation Analysis]
2 Fujikawa H, Okugawa Y, Yamamoto A, Imaoka H, Shimura T, Kitajima T, Kawamura M, Yasuda H, Okita Y, Yokoe T, Ohi M, Toiyama Y. Cumulative C-reactive Protein in the Perioperative Period as a Novel Marker for Oncological Outcome in Patients with Colorectal Cancer Undergoing Curative Resection. J Anus Rectum Colon 2021;5:281-90. [PMID: 34395941 DOI: 10.23922/jarc.2021-013] [Reference Citation Analysis]
3 Farsad-Naeimi A, Alizadeh M, Esfahani A, Darvish Aminabad E. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food Funct 2018;9:2025-31. [PMID: 29541713 DOI: 10.1039/c7fo01898c] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
4 Timudom K, Akaraviputh T, Chinswangwatanakul V, Pongpaibul A, Korpraphong P, Petsuksiri J, Ithimakin S, Trakarnsanga A. Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer. World J Gastrointest Surg 2020; 12(9): 390-396 [PMID: 33024513 DOI: 10.4240/wjgs.v12.i9.390] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim JH, Lee JY, Kim HK, Lee JW, Jung SG, Jung K, Kim SE, Moon W, Park MI, Park SJ. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 2017; 23(3): 505-515 [PMID: 28210087 DOI: 10.3748/wjg.v23.i3.505] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
6 Osterman E, Mezheyeuski A, Sjöblom T, Glimelius B. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort. Ann Surg Oncol 2020;27:1036-45. [PMID: 31893351 DOI: 10.1245/s10434-019-08148-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
7 Barnes EL, Burakoff R. New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflamm Bowel Dis 2016;22:2956-65. [PMID: 27763951 DOI: 10.1097/MIB.0000000000000903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
8 Koper-Lenkiewicz OM, Dymicka-Piekarska V, Milewska AJ, Zińczuk J, Kamińska J. The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location. Diagnostics (Basel) 2021;11:1382. [PMID: 34441316 DOI: 10.3390/diagnostics11081382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Elez E, Gollerkeri A, Maharry K, Christy-Bittel J, Kopetz S. Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study. J Clin Oncol 2021;39:273-84. [PMID: 33503393 DOI: 10.1200/JCO.20.02088] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 16.0] [Reference Citation Analysis]
10 Ito T, Shinkawa H, Takemura S, Tanaka S, Nishioka T, Miyazaki T, Ishihara A, Kubo S. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma. Asian Pac J Cancer Prev 2020;21:2373-9. [PMID: 32856868 DOI: 10.31557/APJCP.2020.21.8.2373] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Saqib R, Pathak S, Smart N, Nunes Q, Rees J, Finch Jones M, Poston G. Prognostic significance of pre-operative inflammatory markers in resected gallbladder cancer: a systematic review: Prognostic significance of pre-operative inflammatory markers. ANZ Journal of Surgery 2018;88:554-9. [DOI: 10.1111/ans.14300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
12 Meng Y, Long C, Huang X, Huang L, Liao L, Tang W, Liu J. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer. Bioengineered 2021;12:5138-48. [DOI: 10.1080/21655979.2021.1960768] [Reference Citation Analysis]
13 Lin ZY, Liang ZX, Zhuang PL, Chen JW, Cao Y, Yan LX, Yun JP, Xie D, Cai MY. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer 2016;16:792. [PMID: 27733196 DOI: 10.1186/s12885-016-2827-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
14 Bruserud Ø, Aarstad HH, Tvedt THA. Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer-What Can We Learn from the Hematological Experience? Cancers (Basel) 2020;12:E1966. [PMID: 32707721 DOI: 10.3390/cancers12071966] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]